Cristiano Ronaldo Invested $7.5 Million in Herbalife Subsidiary
The athlete acquired a 10% equity stake in HBL Pro2col Software LLC, a move disclosed in February 2026.
Updated on Sept. 29, 2026 in Healthcare
Live Poll
Do you think it is a good idea for athletes to become stakeholders in their sponsors?
Cristiano Ronaldo invested $7.5 million for a 10% stake in HBL Pro2col Software LLC, a health-tech subsidiary of Herbalife. The deal was announced in February 2026 alongside the company's fourth-quarter financial results.
Why it matters
The investment represents an expansion of Ronaldo's long-term brand ambassador partnership with Herbalife, which began in 2013. The company has sought to integrate its health-tech platform to generate personalized wellness plans using user data.
Herbalife reported a 6.3% increase in quarterly sales for late 2025, following a year in which its stock price had fallen by roughly two-thirds over five years. The company's share price rose by more than 15% following the investment disclosure.
The players
Cristiano Ronaldo
He is a global football star and brand ambassador who earned an estimated $280 million in 2025.
Herbalife
It is a nutrition company that previously settled with the FTC for $200 million in 2016.
HBL Pro2col Software LLC
It is a health-tech subsidiary of Herbalife that produces personalized wellness plans.
The details
The investment involves a capital infusion into HBL Pro2col Software LLC, which utilizes user-supplied health and lifestyle data to create custom wellness strategies. Ronaldo, who earned an estimated $280 million in 2025, characterized the move as a natural progression of his existing relationship with the firm.
Timeline
2013: Cristiano Ronaldo became a global brand ambassador for Herbalife.
2016: Herbalife finalized a $200 million settlement with the FTC.
Q4 2025: Herbalife experienced a 6.3% increase in quarterly sales.
February 2026: The investment deal was officially disclosed.
Market Landscape
This move signals a strategic pivot for Herbalife as it seeks to revitalize its business model following years of stock decline and the 2016 Herbalife FTC settlement. By deepening ties with a high-profile athlete, the firm aims to capture a larger share of the digital wellness market.
Consumers engaging with Herbalife products may see increased integration of digital health-tech tools as the company develops its Pro2col platform. The partnership suggests a sustained focus on utilizing high-profile brand ambassadors to drive user adoption of wellness technology.
The takeaway
Ronaldo's equity stake underscores the growing trend of celebrity athletes moving from traditional endorsements to direct ownership in parent companies. Investors should monitor whether such high-profile backing can consistently offset long-term fluctuations in legacy company stock prices.
Further reading
For more on the intersection of corporate health initiatives and private investment, visit the Healthcare section.
Live Poll
Do you think it is a good idea for athletes to become stakeholders in their sponsors?
